Surgical treatment for spinal dural arteriovenous fistulas: Outcome, complications and prognostic factors by Wojciechowski, Jakub et al.
Original research article
Surgical treatment for spinal dural arteriovenous
fistulas: Outcome, complications and prognostic
factors
Jakub Wojciechowski, Przemysław Kunert *, Arkadiusz Nowak,
Tomasz Dziedzic, Tomasz Czernicki, Katarzyna Wójtowicz,
Kamil Leśniewski, Andrzej Marchel
Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 4 4 6 – 4 5 3
a r t i c l e i n f o
Article history:
Received 1 March 2017
Accepted 3 July 2017
Available online 10 July 2017
Keywords:
Spinal dural arteriovenous ﬁstula
Spinal vascular malformation
Surgery
Outcome
Complications
a b s t r a c t
Background and purpose: Spinal dural arteriovenous ﬁstulas (SDAVFs) are rare, acquired
pathology and they inevitably lead to severe disability if untreated. The aim of this study
is to present the outcome and complications, and to ﬁnd factors that may affect the outcome
after surgical treatment.
Methods: Seventeen consecutive patients (men – 14, women – 3, age: 41–79) were retrospec-
tively analyzed. The patients presented with paraparesis (88%), bladder symptoms (71%)
and/or sensory disturbances (65%). The ﬁstula was found in the upper thoracic spine in 2
cases, in the lower thoracic (T7–Th12) in 11 cases, and in the lumbar spine in 4 cases.
Microsurgical shunt interruption was performed in all, followed by epidural arteries coagu-
lation in 12 cases.
Results: In the long term, improvement or achievement of a good stable condition was
observed in 13 patients (76%), and no patient deteriorated. All 5 paraplegic patients improved
by at least 1 grade in MCS. Satisfactory results (modiﬁed McCormick Scale grades I–II) were
found in 10 patients (59%), and 15(88%) were independent. Postoperative complications
occurred in 4 patients (24%), two of them (12%) required revision surgery for epidural
hematoma. The success rate was 94%; one patient required revision surgery for recurrent
SDAVF. Better neurological condition on admission ( p = 0.0098) and age >60 years
( p = 0.0498) were the factors associated with satisfactory outcome.
Conclusions: Microsurgical closing of a SDAVF brings good and stable results over time.
Aggressive treatment should be attempted even in cases of total loss of spinal cord function.
Neurological condition before surgery and age may inﬂuence the outcome.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Spinal level Number %
Th2/Th3 1 12
Th5/Th6 1
Th7/Th8 1 65
Th8/Th9 1
Th9/Th10 2
Th11/Th12 3
Th12/L1 4
L1/L2 3 24
L4/L5 11. Introduction
Spinal dural arteriovenous ﬁstulas (SDAVFs) classiﬁed by
Spetzler as intradural dorsal arteriovenous ﬁstulas [1] are the
most common vascular malformation of the spinal cord. They
are acquired and constitute approximately 80% of vascular
malformations in the spinal canal [2]. SDAVFs are rare
pathology with an incidence of 5–10 new cases per million
per year. Most of them are located in the thoracolumbar region
of the spine and they mostly occur in older and middle aged
men. SDAVFs are rare in the sacral region (4%) and rarely may
present as multi-level ﬁstulas (2%) [1,2].
The essence of the disease is a direct connection between
the meningeal arterial branch and the venous coronary plexus
of the spinal cord. This causes a direct transmission of arterial
blood pressure to the venous system which results in venous
stasis in the spinal cord. This is the primary mechanism of
spinal cord damage and may lead to irreversible symptoms [2–
4]. SDAVFs are characterized by slow progressive symptoms
which usually exacerbate with physical effort. Many SDAVFs
remain underdiagnosed as the symptoms may be unspeciﬁc
for along time [2,5].
Currently, microneurosurgical or endovascular methods
may be employed for the treatment of SDAVFs [6,7]. Due to the
rarity of these spinal vascular lesions, reports of their
management and outcomes have been limited to case series
and case reports. The purpose of this paper is to present the
short-term and long-term outcome and postoperative com-
plications, and to ﬁnd factors that may affect the outcome on a
series of 17 surgically treated SDAVFs.
2. Material and methods
2.1. Patients, signs and symptoms
A series of 17 consecutive patients surgically treated for
SDAVFs was retrospectively analyzed. The study group
consisted of 14 men (82%) and 3 women (18%) aged from 41
to 79 years (average – 61 y.o., median – 60 y.o.).
Progressive paraparesis was the most common initial
symptom (n = 10; 59%). Other initial signs and symptoms were:
pain in the lumbosacral region (n = 3; 18%), dysesthesia or
paresthesia in the lower limbs (n = 3; 18%) and intermittent
paraparesis related to physical effort (n = 1; 6%). On admission,
the patients presented with paraparesis (n = 15; 88%), loss of
sphincter control (n = 12; 71%) and sensory disturbances (n = 11;
65%). The symptoms intensiﬁed during effort in ﬁve cases
(29%). According to the modiﬁed McCormick Scale (MCS) [8], 7
patients (41%) presented with good condition (MCS grades I–II)
and 10 (59%) with signiﬁcant deﬁcit (MCS grades III–V, Table 2).
The duration of symptomatic period ranged from 1 to 60
months (average – 18 months; median – 12 months; <6 months
– 3 patients; 7–12 months – 7 patients; >12 months – 7 patients).
2.2. Work-up
All patients underwent preoperative magnetic resonance
imaging (MRI) and digital subtraction angiography (DSA) withselective segmental artery catheterization. All patients had
segmental intramedullary hyperintensive signal on the MRI
T2-weighted images: 3 levels in 2 (12%) cases, 4 levels in 1 (6%)
case, 5 levels in 3 (18%) cases, 6 levels in 4 (24%) cases, 7 levels
in 2 (12%) cases, 8 levels in 1 (6%) case, 9 levels in 3 (18%) cases
and the 10 levels in 1 (6%) case (mean – 6 levels).
In DSA, 16 (94%) SDAVFs presented the arterial supply from
a single radiculomeningeal arterial branch of the correspond-
ing segmental artery. In 1 case (6%), the ﬁstula was supplied
from multiple branches of the segmental artery. The ﬁstula
was found in the upper thoracic spine (Th1–T6) in 2 cases, in
the lower thoracic (T7–Th12) in 11 cases, and in the lumbar
spine in 4 cases (Table 1).
In one patient, after the failed attempt of endovascular
treatment in another center, a closed initial section of the right
segmental artery at the Th12/Th11 level was demonstrated in
DSA. The ﬁstula was supplied by the collateral circulation from
numerous small arteries from the Th11 segmental artery on
the left side.
2.3. Method of outcome evaluation
The modiﬁed McCormick Scale was used to assess the
neurological status [8], and grades I–II were considered as
satisfactory, while grades III–V as unsatisfactory outcome.
Relative evaluation of the outcome was performed compared
to the preoperative condition, according to three possibilities:
1, ‘‘Improved’’ or ‘‘good stable neurological condition’’; 2,
‘‘neurological deﬁcit unchanged’’; 3, ‘‘deterioration’’. ‘‘Good
stable neurological condition’’ was deﬁned as the absence of
neurological deﬁcit before and after surgery (MCS Grade I).
The patients were invited for a check-up outpatient visit
within 2–6 months after surgery. We used data from the last
recorded outpatient visit or data obtained in a telephone
interview to evaluate the long-term outcome. The follow-up
period ranged from 6 to 200 months (average 7 years) and the
data were available for all patients. All patients underwent
follow-up MRI at least 6 months after surgery. The spinal cord
and venous coronary plexus were evaluated on T2-weighted
MRI images. Follow-up DSA was performed only in doubtful
cases, i.e., in patients with neurological deterioration or with
persistent features of SDAVF in an MRI study.
Statistical analysis was conducted to ﬁnd the factors which
may affect long-term outcome and the evolution of a
neurological condition. The following factors were taken into
account: age (<60 y.o. vs. >60 y.o.), sex, neurological status
before surgery (MCS grades I–II vs. MCS grades III–V), symptom
Table 2 – Neurological status of patients before surgery, at discharge, and in long-term follow-up according to the modified
McCormick Scale.
The modiﬁed McCormick scale [8] Neurological condition in different periods
Grade Description At admission At short term
follow-up
At long-term
follow-up
Number (%) Number (%) Number (%)
I Intact neurologically, normal ambulation, minimal dysesthesia 2 (12%) 3 (18%) 5 (29%)
II Mild motor or sensory deﬁcit, functional independence 5 (29%) 6 (35%) 5 (29%)
III Moderate deﬁcit, limitation of function, independent w/external aid 3 (18%) 3 (18%) 5 (29%)
IV Severe motor or sensory deﬁcit, limited function, dependent 2 (12%) 5 (29%) 2 (12%)
V Paraplegia or quadriplegia, even w/ﬂickering movement 5 (29%) 0 0
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vs. lumbar spine), perioperative use of methylprednisolone
and coagulation of extradural arteries in the ﬁstula area.
Fisher's exact test was used to evaluate signiﬁcance and a
p-value < 0.05 was taken as statistically signiﬁcant.
3. Results
3.1. Treatment
All patients underwent microsurgical treatment. Seven
patients (41%) received a perioperative course of methylpred-
nisolone according to the following scheme: an intravenous
bolus of 30 mg/kg over at least 30 min was administered
preoperatively, then an intravenous infusion at a dose of
5.4 mg/kg for 23 h. The operation was performed under
general anesthesia in the prone position. The appropriate
spinal level was determined using C-arm. Hemilaminectomy
was used in 6 patients (35%): 1 level in 3 (18%), 3 levels in
2 (12%), and 4 levels in 1 (6%). Laminectomy was performed
in 11 patients (65%): 1 level in 2 (12%), 2 levels in 7 (41%), and
3 levels in 2 (12%). The ﬁstula was identiﬁed after dural
incision, tracing the course of the outﬂow vein to the place
where it pierced the dura, usually close to the nerve root
sleeve. Then the outﬂow vein was clipped just behind the
ﬁstula location. After a few minutes, when the arterialized
veins on the spinal cord surface collapsed and changed
their color to dark red, the vein was coagulated and
disconnected near the ﬁstula. In 12 cases (71%), epidural
small arteries reaching the ﬁstula were also coagulated as
an adjunctive. This maneuver was abandoned in 5 patients
(29%) because of the ﬁstula location and the higher risk
of Adamkiewicz artery occlusion. Intraoperative neuromoni-
toring (IOM) was used at the beginning of the analyzed
series in 4 patients (24%). The shorter latency and higher
amplitude of responses was noted after ﬁstula closure in all
of these patients. The dura was sutured without additional
sealing materials in 7 patients (41%). In 8 cases (47%) a
Tachosil® (Takeda) was used additionally, in 1 case (6%) ﬁbrin
glue Tissucol® (Baxter) was used, and in 1 case (6%) Tachosil®
and Tissucol® were used simultaneously. The wound
was closed in standard fashion without drainage. Physical
rehabilitation was routinely started from the ﬁrst postopera-
tive day.3.2. Short-term and long-term results of surgery
Improvement or good stable neurological condition was
observed in 11 patients (65%) and no change in 6 patients
(35%) at discharge from hospital. No patient deteriorated
signiﬁcantly when evaluated at discharge, however, transient
deterioration occurred in 3 patients (see: Postoperative
complications). Satisfactory short-term outcome was achieved
in 9 patients (53%) and unsatisfactory in 8 patients (47%).
Most patients (n = 14; 82%) were discharged home with the
recommendation of rehabilitation and 3 patients (18%) were
transferred to a rehabilitation ward.
In the long term, improvement or good stable condition was
observed in 13 patients (76%), stable neurological status in 4
patients (24%) and no patient deteriorated as compared to
the preoperative condition. Neurological improvement by at
least one MCS grade was observed in 11 patients (73%) of the
15 patients with neurological deﬁcit on admission. Notewor-
thy is that all paraplegic patients improved by at least 1 grade
in MCS. Satisfactory long-term results (MCS grades I–II)
were found in 10 patients (59%), and unsatisfactory in 7
patients (41%).
The patient who had had prior failed endovascular
treatment improved slightly after surgery in the long term;
mild paraparesis still remained (MCS grade II).
Follow-up MRI demonstrated the disappearance of both
spinal cord edema and enlarged veins on its surface in all
but one patient (n = 16; 94%). Four patients (24%) underwent
postoperative DSA. The reasons for this examination were:
transient postoperative paraparesis in 2 patients, periodic
difﬁculties in walking 20 months after surgery in 1 patient,
and persistence of SDAVF features in routine follow-up
MRI in 1 patient. The fourth patient presented stable
neurological condition postsurgery, however, DSA conﬁrmed
the SDAVF recurrence only in this one case (6%, see: Treatment
failure).
3.3. Postoperative complications and treatment failure
Postoperative complications. Postoperative complications
occurred in 4 patients (24%) and two of these patients (12%)
required reoperation because of epidural hematoma (EDH). In
the ﬁrst case, the worsening of bladder and motor function
from MCS grade II to grade IV appeared on the 4th postopera-
tive day. During revision surgery, EDH was evacuated and the
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second surgery, an external cerebrospinal ﬂuid (CSF) leak
appeared and needed surgical treatment. In long-term follow-
up, the patient achieved signiﬁcant improvement (MCS
grade II).
The second patient presented with severe deﬁcit before
surgery (MCS grade IV). After surgery, the patient achieved
improvement to MCS grade III, but deteriorated again to pre-
surgery status (MCS grade IV) on the 4th postoperative day.
EDH was urgently evacuated. After several days of temporary
improvement, re-aggravation of symptoms occurred. MRI
revealed a restriction of the subarachnoid space at the surgery
level, while DSA conﬁrmed the ﬁstula closure (Fig. 1). During
the third surgery, duroplasty was performed to expand the
dural sac. The postsurgery period was complicated with a CSF
leak, which was treated by lumbar drainage. In the long term,
the patient achieved an improvement; she can walk for short
distances (MCS grade III).
The remaining 2 complications were treated conservative-
ly: (1) pneumonia, (2) transient worsening of motor function
related to a small EDH. This last patient achieved a good
functional outcome (MCS grade I) in the long term.
3.4. Treatment failure.
One patient (6%) required revision surgery for recurrent
ﬁstula. Preoperative DSA showed SDAVF on the Th11/Th12
level. The ﬁstula was disconnected in a standard fashion, but
the epidural arteries were not coagulated. After the surgery,
bladder and motor function improved (MCS grade II), and this
condition was stable in follow-up. The scheduled MRI,
performed 1 year after surgery, found indirect features of
SDAVF and ﬁstula recurrence was conﬁrmed by DSA. During
the second surgery, two new outﬂow veins of the ﬁstula
located at the same level were found next to the clip
previously left. The veins were disconnected with additional
coagulation of extradural arteries around the ﬁstula. After the
operation, further improvement of the neurological condition
was observed (MCS grade I).
3.5. Factors that may affect the outcome
An analysis of factors that may affect the long-term outcome
and the evolution of the functional status is presented in
Tables 3 and 4. Good neurological condition before surgery
and age >60 years were the factors signiﬁcantly associated
with better functional outcome. We failed to ﬁnd factors
signiﬁcantly related with the functional status evolution after
surgery. We also found no signiﬁcant relationship between
the functional outcome and longer symptom duration.
Satisfactory long-term results were found in 7 (64%) out
11 patients with symptom duration ≤2 years and in 3 (50%)
out 6 patients with longer symptomatic period ( p = 1).
4. Discussion
Spinal vascular malformations constitute about 3–4% of all
intradural spinal lesions and 5–9% of all vascular malforma-
tions of the central nervous system [9]. The most common ofthese are spinal dural arteriovenous ﬁstulas which constitute
approximately 80% of all vascular malformations within the
spinal canal [10]. The etiology is not clearly understood, but it
is widely accepted that they are acquired and they are most
common in middle-aged and older men [7,9,10]. Untreated
SDAVF inevitably leads to severe disability [7,9–11].
4.1. Microsurgical treatment
The ﬁrst attempts of surgical treatment of spinal vascular
malformations have been reported from 1910, when Fedor
Krause intraoperatively found a vascular malformation of
the spinal cord. A few years later, Charles Ellsberg was the ﬁrst
to attempt the surgical excision of a spinal vascular
malformation [9,12,13]. Kendall and Logue described the
pathophysiology of SDAVF in 1977. They found that the
expanded veins of the coronary plexus are normal veins
but dilated as a result of diversion of arterial blood from the
dural ﬁstula [12,14,15]. Since then, the surgical procedure
has not changed signiﬁcantly. The idea is that the ﬁstula
must be disconnected. However, they proposed additional
excision of the dura mater to avoid the recurrence of the
ﬁstula [16,17]. Simple intradural disconnection of the ﬁstula
is now a widely used surgical technique, together with
additional coagulation of the arteries on the external surface
of the dura. It is only near the Adamkiewicz artery that
this should not be performed [3,9,18,19]. In recent years, a
trend toward minimizing the surgical approach has appeared,
e.g., the microscope-assisted endoscopic interlaminar ap-
proach or the hemilaminectomy approach using a tubular
retractor [20,21].
Currently, the use of IOM is suggested by some centers as a
useful tool for monitoring neurological status after closing the
ﬁstula [9,22]. At the beginning of our series, IOM was used in 4
patients (25%). The responses of motor and somatosensory
evoked potentials improved quickly in all patients after the
closure of the ﬁstula. This group is too small to draw
deﬁnite conclusions. However, we do not currently use
IOM, because in our experience it does not offer any beneﬁt
for this procedure.
The use of methylprednisolone in our series was not
routine and was dependent on the severity of the neurological
deﬁcit before surgery. In addition, the indications for this
management have been changing in recent years. In our
series, we found no signiﬁcant association between the use of
methylprednisolone and outcomes. In the available literature,
there is no data on the rationale for the use of steroids in the
perioperative period. However, a few cases of rapid deteriora-
tion after steroid administration in patients with SDAVF were
reported [23,24].
Endovascular methods are an alternative to surgery.
However, they are associated with a higher risk of ﬁstula
recurrence and occlusion of the radiculomeningeal arterial
branch involved in the vascularization of the spinal cord [3].
The difﬁculties in reaching the exact site of the ﬁstula by
microcatheters and the poor penetration of embolic agents
into the ﬁstula are also reported [25–28]. It seems that the
microsurgical method currently offers greater efﬁcacy (success
rate: 80–98%), as compared to endovascular procedures
(success rate: 46–72%) [19,27,28].
Fig. 1 – Preoperative magnetic resonance imaging (MRI) and digital subtraction angiography (DSA) with selective segmental
artery catheterization. (A) T2-weighted sagittal magnetic resonance imaging (MRI) showed the hyperintensive
intramedullary signal in the thoracic spinal cord and conus medullaris (myelopathy). Enlarged perimedullary veins are
present along the dorsal surface of the spinal cord. (B) DSA in the anterior–posterior projection (a–p) of the left T9 radicular
artery showing draining vein and dilated, tortuous, perimedullary veins. (C) DSA the same artery in the lateral projection. (D)
Postoperative DSA in a–p projection confirmed the fistula closure. The clip after the fistula closure is visible in the spinal
canal (arrow). (E) T2-weighted MRI after the second operation revealed the restriction of cerebrospinal fluid layer around the
spinal cord at the surgery level.
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The functional results of surgery for SDAVF are acceptable and
the risk of ﬁstula recurrence is low. Saladino et al. presented a
series of 154 patients with an average age of 64 years, with a
3.5:1 male to female ratio, with a predilection for the
occurrence of ﬁstulas in the thoracic region. Among the 141
patients with available long-term follow-up, [23] improvement
in motor function was observed in 82.2%, and stable conditionin 14.4% [19]. Cenzato et al. presented data from three centers
on 65 patients, of which 10 were treated endovascularly and 55
surgically. In short-term follow-up (6 months), 80% of the
patients showed functional improvement (mainly motor
function – 63%) and 69% of the patients improved in the long
term [2]. In our series, functional improvement or good stable
condition was achieved in 65% of the patients at discharge and
in 76% in long-term follow-up. The demographic proﬁle and
the location of the ﬁstulas were similar to the other series.
Table 3 – Analysis of factors that might influence long-term outcome.
Factor Long-term outcome (MCS) p-value
(the Fisher Exact test)
Grades I–II Grades III–V
Age ≤60 y.o. 3 (32%) 6 (67%) p = 0.0498
>60 y.o 7 (88%) 1 (13%)
Gender Female 1 (32%) 2 (67%) p = 0.5368
Male 9 (63%) 5 (36%)
Neurological condition at admission (MCS) Grades I–II 7 (100%) 0 (0%) p = 0.0098
Grades III–IV 3 (30%) 7 (70%)
Symptomatic period ≤1 year 6 (60%) 4 (40%) p = 1.0000
>1 year 4 (56%) 3 (43%)
SDAVF location Thoracic spine 7 (54%) 6 (45%) p = 0.6221
Lumbar spine 3 (75%) 1 (25%)
Perioperative use of methylprednisolonum /+/ 1 (14%) 6 (86%) p = 0.133998
// 6 (60%) 4 (40%)
Epidural vessels coagulation /+/ 5 (45%) 6 (55%) p = 1
// 2 (33%) 4 (67%)
MCS = modiﬁed McCormick Scale, SDAVF = spinal dural arteriovenous ﬁstula.
Table 4 – Analysis of factors that might influence the evolution of neurological condition from admission to the long term.
Factor Long-term outcome (MCS) p value
(the Fisher Exact test)
Improvement or
stable good
neurological condition
Stable neurological
deﬁcit or
deterioration
Age ≤60 y.o. 6 (67%) 3 (33%) p = 0.576471
>60 y.o 7(88%) 1 (13%)
Gender Female 3 (100%) 0 (0%) p = 0.541176
Male 10 (71%) 4 (29%)
Neurological condition at admission (MCS) Grades I–II 6 (86%) 1 (14%) p = 0.60294
Grades III–IV 7 (70%) 3 (30%)
Symptomatic period ≤1 year 6 (60%) 4 (40%) p = 0.10294
>1 year 7 (100%) 0 (0%)
SDAVF location Thoracic spine 9 (69%) 4 (31%) p = 0.51932
Lumbar spine 4 (100%) 0 (0%)
Perioperative use of methylprednisolonum /+/ 5 (71%) 2 (29%) p = 1
// 8 (80%) 2 (20%)
Epidural vessels coagulation /+/ 8 (73%) 3 (27%) p = 1
// 5 (83%) 1 (17%)
MCS = modiﬁed McCormick Scale, SDAVF = spinal dural arteriovenous ﬁstula.
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Postoperative complications occurred in 4 patients (24%) in our
series, including 3 patients (18%) with transient worsening of
neurologic status. Complications included: EDH (n = 3), CSF
leak (n = 2) and pneumonia (n = 1). Saladino et al. reported
functional deterioration or a new deﬁcit in 16% (including
permanent deterioration in 2.6%), gait deterioration in 0.6%,
abnormal urination in 1.9%, surgical wound infection in 1.3%
and deep vein thrombosis in 1.9% [19]. Steinmetz et al.
observed pseudomeningocele in one case (5%) [28]. Ropper
et al. in a series of 15 patients reported transient paresis in 13%
and epidural hematoma in 7% [14].
4.4. Treatment failure
The success rate in our series was 94%, with only 1 patient
requiring revision surgery for recurrent SDAVF. In the series of
Saladino et al., two patients (1.3%) with neurological deﬁcitrequired reoperation because of incomplete disconnection of
the ﬁstula [19]. A comparative analysis of MRI before and after
treatment was carried out by Kaufman et al. on a group of 34
patients [29]. The authors noted that MRI does not always
correlate with clinical status. Follow-up DSA was performed on
10 patients (29%) due to their clinical condition and 3 of them
(9%) had recurrent ﬁstula. However, only 2 patients presented
subtle changes in the MR imaging of the spinal cord. The
authors suggest that DSA should be performed in any clinically
doubtful case, even if MRI reveals no pathological changes.
4.5. Factors that might inﬂuence the outcome
We failed to ﬁnd factors that would inﬂuence the evolution of
the neurological condition after surgery (Table 4). However, we
found that better neurological condition on admission and
older age are factors that are associated with better outcome in
the long term. It is not surprising that all patients with good
condition and only 30% of the patients with signiﬁcant deﬁcit
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term functional result (MCS grades I–II, p = 0.0098). Apparently,
this is due to irreversible damage to the spinal cord before
surgery in patients with severe deﬁcits [2]. On the other hand,
it must be emphasized that all paraplegic patients improved by
at least 1 grade in MCS. Therefore, aggressive treatment should
be attempted even in cases of total loss of spinal cord function.
Nevertheless, it would be interesting to know why patients
over the age of 60 years achieved better results than their
younger counterparts (MCS grades I–II, 88% vs. 32%, p = 0.0498).
The borderline statistical results and the low number of
patients may suggest that this is only an accidental ﬁnding
that needs to be conﬁrmed in a study with a larger series (this
implies that this ﬁnding might disappear as the size of the
series increases). Furthermore, 63% (5/8) of older patients, and
only 22% (2/9, p – non signiﬁcant) of younger patients
presented with good preoperative condition (MCS grades I–
II) in our series. On the other hand, it is also possible that the
aging process in the spinal cord may help to tolerate some
pathological processes as occurs in the aging brain, e.g., in case
of chronic subdural hematoma [30,31]. However, Cenzato et al.
observed faster recovery after surgery in younger patients, but
the difference was not statistically signiﬁcant [2].
We found no signiﬁcant relations between the functional
outcome and the following factors: gender, symptomatic
period, level of SDAVF, steroid neuroprotection and epidural
vessel coagulation. However, Cenzato et al. observed a
relationship between the level of the ﬁstula and the outcomes
[2]. The authors obtained better results when the ﬁstula was
located in the lower thoracic spine and they explained that this
was as a result of better anatomical vascularization of this
region of the spinal cord by the Adamkiewicz artery.
5. Conclusions
Intradural, microsurgical closing SDAVF brings good and
stable results over time. All paraplegic patients improved by
at least 1 grade in MCS after surgery, therefore, aggressive
treatment should be attempted even in cases of total loss of
spinal cord function. The only case of SDAVF recurrence after
disconnection alone indicates that the additional coagulation
of the epidural vessels is reasonable.
Disclosure
The authors have no personal ﬁnancial or institutional interest
in any of the drugs, materials, or devices described in this article.
Conﬂict of interest
None declared.
Acknowledgement and ﬁnancial support
None declared.r e f e r e n c e s
[1] Spetzler RF, Detwiler PW, Riina HA, Porter RW. Modiﬁed
classiﬁcation of spinal cord vascular lesions. J Neurosurg
2002;96:145–56.
[2] Cenzato M, Debernardi A, Steﬁni R, D'Aliberti G, Piparo M,
Talamonti G, et al. Spinal dural arteriovenous ﬁstulas:
outcome and prognostic factors. Neurosurg Focus 2012;32:
E11.
[3] Marcus J, Schwarz J, Singh IP, Sigounas D, Knopman J, Gobin
YP, et al. Spinal dural arteriovenous ﬁstulas: a review. Curr
Atheroscler Rep 2013;15:335.
[4] Schuss P, Daher FH, Greschus S, Vatter H, Guresir E. Surgical
treatment of spinal dural arteriovenous ﬁstula:
management and long-term outcome in a single-center
series. World Neurosurg 2015;83:1002–5.
[5] Jellema K, Tijssen CC, Sluzewski M, van Asbeck FWA,
Koudstaal PJ, van Gijn J. Spinal dural arteriovenous ﬁstulas
– an underdiagnosed disease. A review of patients admitted
to the spinal unit of a rehabilitation center. J Neurol
2006;253:159–62.
[6] Sivakumar W, Zada G, Yashar P, Giannotta SL, Teitelbaum
G, Larsen DW. Endovascular management of spinal dural
arteriovenous ﬁstulas. A review. Neurosurg Focus 2009;26:
E15.
[7] Qi X, Lv L, Han K, Xu Z, Mei Q, Chen H, et al. Analysis of the
embolization spinal dural arteriovenous ﬁstula and surgical
treatments on 52 cases of the patients. Int J Clin Exp Med
2014;7:3062–71.
[8] McCormick PC, Torres R, Post KD, Stein BM. Intramedullary
ependymoma of the spinal cord. J Neurosurg 1990;72:523–32.
[9] Flores BC, Klinger DR, White JA, Batjer HH. Spinal vascular
malformations: treatment strategies and outcome.
Neurosurg Rev 2016.
[10] Eskandar EN, Borges LF, Budzik Jr RF, Putman CM, Ogilvy
CS. Spinal dural arteriovenous ﬁstulas: experience with
endovascular and surgical therapy. J Neurosurg
2002;96:162–7.
[11] Rangel-Castilla L, Russin JJ, Zaidi HA, Martinez-Del-Campo
E, Park MS, Albuquerque FC, et al. Contemporary
management of spinal AVFs and AVMs: lessons learned
from 110 cases. Neurosurg Focus 2014;37:E14.
[12] Black P. Spinal vascular malformations: an historical
perspective. Neurosurg Focus 2006;21:E11.
[13] Tacconi L, Lopez Izquierdo BC, Symon L. Outcome and
prognostic factors in the surgical treatment of spinal dural
arteriovenous ﬁstulas. A long-term study. Br J Neurosurg
1997;11:298–305.
[14] Ropper AE, Gross BA, Du R. Surgical treatment of Type I
spinal dural arteriovenous ﬁstulas. Neurosurg Focus
2012;32:E3.
[15] Kendall BE, Logue V. Spinal epidural angiomatous
malformations draining into intrathecal veins.
Neuroradiology 1977;13:181–9.
[16] Afshar JK, Doppman JL, Oldﬁeld EH. Surgical interruption of
intradural draining vein as curative treatment of spinal
dural arteriovenous ﬁstulas. J Neurosurg 1995;82:196–200.
[17] Oldﬁeld EH, Di Chiro G, Quindlen EA, Rieth KG, Doppman JL.
Successful treatment of a group of spinal cord
arteriovenous malformations by interruption of dural
ﬁstula. J Neurosurg 1983;59:1019–30.
[18] Gemmete JJ, Chaudhary N, Elias AE, Toma AK, Pandey AS,
Parker RA, et al. Spinal dural arteriovenous ﬁstulas: clinical
experience with endovascular treatment as a primary
therapy at 2 academic referral centers. AJNR: Am J
Neuroradiol 2013;34:1974–9.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 4 4 6 – 4 5 3 453[19] Saladino A, Atkinson JL, Rabinstein AA, Piepgras DG, Marsh
WR, Krauss WE, et al. Surgical treatment of spinal dural
arteriovenous ﬁstulae: a consecutive series of 154 patients.
Neurosurgery 2010;67:1350–7. discussion 1357–8.
[20] Patel NP, Birch BD, Lyons MK, DeMent SE, Elbert GA.
Minimally invasive intradural spinal dural arteriovenous
ﬁstula ligation. World Neurosurg 2013;80:e267–70.
[21] Wang C, Chen C-M, Shen F, Fang X-D, Ying G-Y, Ren Y-C,
et al. Microscope-assisted endoscopic interlaminar ligation
of spinal arteriovenous ﬁstulas: technical note. J Neurosurg
Spine 2016;25:394–7.
[22] Chibbaro S, Gory B, Marsella M, Tigan L, Herbrecht A, Orabi
M, et al. Surgical management of spinal dural arteriovenous
ﬁstulas. J Clin Neurosci Off J Neurosurg Soc Aust
2015;22:180–3.
[23] Cabrera M, Paradas C, Marquez C, Gonzalez A. Acute
paraparesis following intravenous steroid therapy in a case
of dural spinal arteriovenous ﬁstula. J Neurol
2008;255:1432–3.
[24] Soderlund ME, Benisty S, Gaston A, Djindjian M, Cesaro P,
Creange A. Les myelopathies secondaires aux ﬁstules
durales arterio-veineuses peuvent-elles etre aggravees par
la corticotherapie intraveineuse? Rev Neurol 2007;163:235–
7.
[25] Blackburn SL, Kadkhodayan Y, Ray WZ, Zipfel GJ, Cross 3rd
DT, Moran CJ, et al. Onyx is associated with poor venouspenetration in the treatment of spinal dural arteriovenous
ﬁstulas. J Neurointervent Surg 2014;6:536–40.
[26] Clark S, Powell G, Kandasamy J, Lee M, Nahser H, Pigott T.
Spinal dural arteriovenous ﬁstulas – presentation,
management and outcome in a single neurosurgical
institution. Br J Neurosurg 2013;27:465–70.
[27] Bakker NA, Uyttenboogaart M, Luijckx GJ, Eshghi OS, Mazuri
A, Metzemaekers JD, et al. Recurrence rates after surgical or
endovascular treatment of spinal dural arteriovenous
ﬁstulas: a meta-analysis. Neurosurgery 2015;77:137–44.
discussion 144.
[28] Steinmetz MP, Chow MM, Krishnaney AA, Andrews-
Hinders D, Benzel EC, Masaryk TJ, et al. Outcome after the
treatment of spinal dural arteriovenous ﬁstulae: a
contemporary single-institution series and meta-analysis.
Neurosurgery 2004;55:77–87. discussion 87–8.
[29] Kaufmann TJ, Morris JM, Saladino A, Mandrekar JN, Lanzino
G. Magnetic resonance imaging ﬁndings in treated spinal
dural arteriovenous ﬁstulas: lack of correlation with clinical
outcomes. J Neurosurg Spine 2011;14:548–54.
[30] Konig K, Heissler HE, Zumkeller M, Rickels E. Age-
dependence of cerebrospinal parameters. Acta Neurochir
Suppl 2005;95:315–8.
[31] Sundstrom T, Helland CA, Aarhus M, Wester K. What is the
pressure in chronic subdural hematomas?. A prospective,
population-based study. J Neurotrauma 2012;29:137–42.
